Bicalutamide Tablet IP 50mg
BICALIEVA contains Bicalutamide, a non-steroidal anti-androgen. It works by blocking androgen receptors, preventing testosterone from stimulating prostate cancer cell growth.
View Details
Abiraterone Acetate Tablets IP 500mg
ABIRALIEVA 500 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It blocks the enzyme CYP17 (17α-hydroxylase/17,20-lyase), which is essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This results in profound suppression of circulating and intratumoral androgens, slowing prostate cancer growth.
View Details
Abiraterone Acetate Tablets IP 25mg
ABIRALIEVA 250 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It works by irreversibly inhibiting CYP17 (17α-hydroxylase/17,20-lyase), an enzyme essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This leads to profound suppression of androgen levels and slows prostate cancer progression.
View Details
Enzalutamide Capules 40mg
ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.
View Details
Enzalutamide Capules 40mg
ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.
View Details
